Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
In this randomized, controlled trial the investigators evaluate the effects of an exercise program lasting for 12 weeks on the physical performance, the cardiovascular function (24h blood pressure, rest blood pressure and hear function) and the fatigue and mood of patients with renal cell carcinoma undergoing a therapy with Sunitinib.
Epistemonikos ID: 756bf8fc401e3a8976b867a60e54e48f086dbd91
First added on: May 05, 2024